NDC 50090-2623 – Terazosin

Terazosin Hydrochloride 2 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC50090-2623

Product details

Brand name
Terazosin
Generic name
Terazosin Hydrochloride
Labeler
A-S Medication Solutions
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075317
Marketed since
December 20, 2004
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (2)

Package NDCDescriptionSince
50090-2623-030 CAPSULE in 1 BOTTLE (50090-2623-0)Nov 16, 2016
50090-2623-190 CAPSULE in 1 BOTTLE (50090-2623-1)Aug 30, 2018

Other Terazosin products